Results 211 to 220 of about 871,284 (309)
Editorial: Cellular replacement therapy for diabetes. [PDF]
Sakata N, Yoshimatsu G, Kodama S.
europepmc +1 more source
Natural products target the aging kidney in diabetic nephropathy by restoring the AMPK–SIRT1–Nrf2 axis, reducing oxidative stress, inflammation, fibrosis, and cellular senescence while enhancing mitochondrial biogenesis and antioxidant defenses.
Sherif Hamidu +8 more
wiley +1 more source
Bovine Viral Diarrhea Virus and Vaccine Protection Strategies. [PDF]
Hu X, Huang J, Cai Y, Zhang W, Cheng Y.
europepmc +1 more source
Aging Is a Key Driver for Adult Acute Myeloid Leukemia
Acute myeloid leukemia (AML) is a classical age‐related hematologic malignancy, and a key driver of AML is aging, which profoundly regulates intrinsic factors such as genomic instability, epigenetic reprogramming, and metabolic dysregulation, and alters bone marrow microenvironment.
Rong Yin, Haojian Zhang
wiley +1 more source
Challenges in the standardization of innate immune status assessment. [PDF]
Liu Y +11 more
europepmc +1 more source
Mutant NPM1 in Acute Myeloid Leukemia Initiation and Maintenance
NPM1 mutations drive acute myeloid leukemia by acting as neomorphic transcriptional regulators that cooperate with Menin–MLL and XPO1 to sustain HOX/MEIS1 expression and block differentiation. Targeting these mutant‐specific transcriptional dependencies provides a rational therapeutic strategy for NPM1‐mutated AML.
Yanan Jiang +3 more
wiley +1 more source
Comparative Immunomodulatory Profiles of <i>Bifidobacterium animalis</i> subsp. <i>lactis</i> HOM2120 and <i>Bifidobacterium longum</i> subsp. <i>longum</i> HOM1190: Insights from Genomics, <i>In Vitro</i>, and <i>In Vivo</i> Studies. [PDF]
Wang T +7 more
europepmc +1 more source
This systematic review synthesizes prognostic models for survival and recurrence in resected non‐small cell lung cancer. While many models demonstrate moderate to good discrimination, few are externally validated and reporting quality is variable, limiting clinical applicability and highlighting the need for robust, transparent model development ...
Evangeline Samuel +4 more
wiley +1 more source
Challenges and Prospects in the Development of a Universal SARS-CoV-2 Vaccine. [PDF]
Karczmarzyk K, Kęsik-Brodacka M.
europepmc +1 more source

